Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Safety and PK/PD of DW1903 in Healthy Volunteers
NCT05155072Phase 1Completed
- Sponsor
- Daewon Pharm
- Start
- May 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Escorten in gastritis (6 arms), sponsored by Daewon Pharm. Primary endpoint: pH monitoring. Started May 2020; status: completed.
02
Drugs
Escorten
03
Conditions
gastritis
Beyond the preview
Go deeper on NCT05155072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05155072.